128 related articles for article (PubMed ID: 9408856)
21. Pharmacokinetic properties of indinavir in rat: some limitations of noncompartmental analysis.
Hamidi M
Drug Dev Ind Pharm; 2010 Mar; 36(3):355-61. PubMed ID: 19722914
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
23. Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects.
Patat A; Stubbs D; Dunmore C; Ulliac N; Sexton B; Zieleniuk I; Irving A; Jones W
Eur J Clin Pharmacol; 1995; 48(2):143-50. PubMed ID: 7589029
[TBL] [Abstract][Full Text] [Related]
24. Estimation of in vivo percutaneous absorption of emedastine from bile excretion data using a deconvolution method.
Harada S; Yamashita F; Hashida M
Drug Metab Pharmacokinet; 2005 Oct; 20(5):331-6. PubMed ID: 16272750
[TBL] [Abstract][Full Text] [Related]
25. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects.
Pue MA; Laroche J; Meineke I; de Mey C
Eur J Clin Pharmacol; 1993; 44(6):575-8. PubMed ID: 8405016
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers.
Stangier J; Su CA; Schöndorfer G; Roth W
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1355-64. PubMed ID: 11185634
[TBL] [Abstract][Full Text] [Related]
29. Application of a dual mechanistic approach to support bilastine dose selection for older adults.
Kim C; Lo Re V; Rodriguez M; Lukas JC; Leal N; Campo C; García-Bea A; Suarez E; Schmidt S; Vozmediano V
CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1006-1017. PubMed ID: 34157202
[TBL] [Abstract][Full Text] [Related]
30. Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients.
Cosson VF; Fuseau E
J Pharmacokinet Biopharm; 1999 Apr; 27(2):149-71. PubMed ID: 10567953
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
Bizikova P; Papich MG; Olivry T
Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses.
Kuroda T; Nagata S; Takizawa Y; Tamura N; Kusano K; Mizobe F; Hariu K
Vet J; 2013 Aug; 197(2):433-7. PubMed ID: 23489843
[TBL] [Abstract][Full Text] [Related]
34. The comparative pharmacokinetics of H1-receptor antagonists.
Simons FE; Simons KJ; Chung M; Yeh J
Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of D(+)-usnic acid in rabbits after intravenous and oral administration.
Krishna DR; Venkataramana D
Drug Metab Dispos; 1992; 20(6):909-11. PubMed ID: 1362945
[TBL] [Abstract][Full Text] [Related]
36. Biopharmaceutical considerations on antihistamine effects of topically administered emedastine.
Harada S; Nakada Y; Yamashita F; Hashida M
J Pharm Sci; 2005 Jan; 94(1):17-24. PubMed ID: 15761926
[TBL] [Abstract][Full Text] [Related]
37. Compartmental mean residence time in a mammillary model with an effect compartment after intravenous or oral administration.
Plusquellec Y; Houin G
J Biomed Eng; 1990 Nov; 12(6):523-6. PubMed ID: 2266749
[TBL] [Abstract][Full Text] [Related]
38. Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.
Golabchifar AA; Rezaee S; Dinan NM; Kebriaeezadeh A; Rouini MR
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):527-39. PubMed ID: 26189007
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of acrivastine after oral and colonic administration.
Balasubramanian R; Klein KB; Pittman AW; Liao SH; Findlay JW; Frosolono MF
J Clin Pharmacol; 1989 May; 29(5):444-7. PubMed ID: 2567739
[TBL] [Abstract][Full Text] [Related]
40. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
